Holen Sie sich die Stockscreener-App
1.61
6.43%
-0.10
Codexis Inc Aktie (CDXS) Neueste Nachrichten
Cantor Fitzgerald Maintains Overweight on Codexis (CDXS) March 2026 - Meyka
Why Did Codexis (CDXS) Stock Soar Nearly 38% After Hours? - Sahm
Codexis (CDXS) Stock Jumps 2.4% Following Strong Q4 Earnings Report - MEXC
Codexis (CDXS) Q4 Profit Turns Positive EPS Into Test Of Turnaround Narrative - simplywall.st
Cantor Fitzgerald reiterates Codexis stock rating on siRNA deal - Investing.com South Africa
Codexis Posts Strong Q4, Eyes siRNA Market With ECO Synthesis Platform (NASDAQ:CDXS) - Seeking Alpha
Codexis (CDXS) Stock Rises 2.4% After Q4 Earnings Beat - MEXC
Cantor Fitzgerald reiterates Codexis stock rating on siRNA deal By Investing.com - Investing.com India
Crude Oil Surges Over 8%; Dollar General Shares Fall After Q4 Results - Benzinga
Codexis Shines as Q4 Profit Sparks Investor Enthusiasm - StocksToTrade
Stifel reiterates Codexis stock Buy rating on solid 2026 guidance - Investing.com
Codexis Surpasses Q4 Expectations, Stock Price Volatility Anticipated - timothysykes.com
Dow Tumbles Over 1%; US Weekly Jobless Claims Fall - Benzinga
Codexis (CDXS) Surges on Strong Q4 2025 Results and Optimistic O - GuruFocus
Codexis rises after Q4 beat, strong outlook - MSN
Codexis, Inc. (NASDAQ:CDXS) Q4 2025 Earnings Call Transcript - Insider Monkey
Codexis stock rises after Q4 beat, outlook (CDXS:NASDAQ) - Seeking Alpha
Why did Codexis (CDXS) stock soar nearly 38% after hours? - MSN
Codexis, Inc. 2025 Annual Report: Advancements in ECO Synthesis Platform and Pharma Biocatalysis for Therapeutics Manufacturing - Minichart
Codexis: Q4 Earnings Snapshot - theheraldreview.com
Codexis (CDXS) Expects Current Funds to Last Through 2027 - GuruFocus
Codexis Inc (CDXS) Q4 2025 Earnings Call Highlights: Revenue Surge and Strategic Partnerships ... By GuruFocus - Investing.com Canada
Codexis, Inc. Q4 2025 Earnings Call Summary - Yahoo Finance
Codexis (CDXS) Q4 2025 Earnings Call Transcript - The Globe and Mail
Codexis (CDXS) Surpasses Q4 Expectations for Earnings and Revenue - Bitget
Earnings call transcript: Codexis Surpasses Q4 2025 Expectations with Strong Revenue Growth - Investing.com Canada
CDXS: Strong 2025 revenue and ECO Synthesis progress set the stage for continued growth in 2026 - TradingView
Codexis Q4 Earnings Call Highlights - Yahoo Finance
Codexis (CDXS) Beats Q4 Earnings and Revenue Estimates - Yahoo Finance
Codexis (CDXS) Exceeds Revenue Expectations, Highlights Technolo - GuruFocus
Codexis Q4 2025 Results: $9.6M Profit, 2026 Revenue Forecast $72M-$76MNews and StatisticsIndexBox - IndexBox - Market Intelligence Platform
Codexis 2025 10-K: Revenue $70.4M, EPS $(0.50) - TradingView
Codexis (NASDAQ:CDXS) Releases Earnings Results, Beats Expectations By $0.10 EPS - MarketBeat
CODEXIS ($CDXS) Releases Q4 2025 Earnings, Stock Rises - Quiver Quantitative
Codexis Q4 Swings to Profit, Revenue Rises - marketscreener.com
Codexis Reports Fourth Quarter and Fiscal Year 2025 Financial Results - The Manila Times
Codexis swings to Q4 profit as Merck deal lifts revenue and funds RNAi push - Stock Titan
Preview: Codexis's Earnings - Benzinga
Codexis signs deal to produce siRNA for pharma partner - Investing.com Nigeria
Codexis Inc expected to post a loss of 4 cents a shareEarnings Preview - TradingView
Codexis Targets 2026 Inflection as CEO Touts ECO Synthesis Push in RNA Manufacturing at TD Cowen Conf - MarketBeat
Why did CDXS stock jump 7% today? - MSN
Update Recap: Whats next for Codexis Inc stockJuly 2025 Snapshot & Accurate Buy Signal Notifications - baoquankhu1.vn
Why Did CDXS Stock Jump 7% Today? - Stocktwits
Codexis, Inc. Hits New 52-Week Low at $0.96 Amid Financial Struggles - Markets Mojo
Clean the SkyClean Pharmaceutical Manufacturings - Trend Hunter
Codexis signs deal to produce siRNA for pharma partner By Investing.com - Investing.com Canada
Codexis to Produce 50 Grams of siRNA Using ECO Synthesis Manufacturing Platform - geneonline.com
Codexis Agrees to Manufacture 50 Grams of siRNA Using its Proprietary Manufacturing Platform - Contract Pharma
Codexis (CDXS) Partners for siRNA Manufacturing in Cardiovascula - GuruFocus
Biotech Codexis tapped to scale RNA ingredient for heart drug research - Stock Titan
Codexis signs agreement to manufacture 50 g siRNA using its ECO Synthesis® Manufacturing Platform - Yahoo Finance
Codexis at TD Cowen Conference: Strategic Shift to RNA Medicines - Investing.com
Codexis at TD Cowen Conference: Strategic Shift to RNA Medicines By Investing.com - Investing.com Canada
CDXS SEC FilingsCodexis Inc 10-K, 10-Q, 8-K Forms - Stock Titan
CDXS Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
0.41%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):